Drug results: 2
| aclidinium bromide | a long-acting, inhaled antimuscarinic; in phase I trial 8/2008 |
|
| formoterol | An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. |
|








Citing DrugCentral © 2025.
License